BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33115904)

  • 1. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
    Al-Shamsi S; Govender RD; King J
    BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Framingham coronary heart disease risk score for predicting 10-year cardiac risk in adult United Arab Emirates nationals without diabetes: a retrospective cohort study.
    Al-Shamsi S
    BMC Fam Pract; 2020 Aug; 21(1):175. PubMed ID: 32847496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel 10-year cardiovascular risk prediction nomogram for the United Arab Emirates national population.
    Al-Shamsi S
    BMJ Open; 2022 Dec; 12(12):e064502. PubMed ID: 36581433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the REduction of Atherothrombosis for Continued Health (REACH) prediction model for recurrent cardiovascular disease among United Arab Emirates Nationals.
    Al-Shamsi S; Govender RD
    BMC Res Notes; 2020 Oct; 13(1):484. PubMed ID: 33076967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agreement between cardiovascular disease risk assessment tools: An application to the United Arab Emirates population.
    Oulhaj A; Bakir S; Aziz F; Suliman A; Almahmeed W; Sourij H; Shehab A
    PLoS One; 2020; 15(1):e0228031. PubMed ID: 31978187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis.
    Wallisch C; Heinze G; Rinner C; Mundigler G; Winkelmayer WC; Dunkler D
    Int J Cardiol; 2019 May; 283():165-170. PubMed ID: 30429082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis.
    Damen JA; Pajouheshnia R; Heus P; Moons KGM; Reitsma JB; Scholten RJPM; Hooft L; Debray TPA
    BMC Med; 2019 Jun; 17(1):109. PubMed ID: 31189462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China.
    Jiang Y; Ma R; Guo H; Zhang X; Wang X; Wang K; Hu Y; Keerman M; Yan Y; Ma J; Song Y; Zhang J; He J; Guo S
    BMC Public Health; 2020 Sep; 20(1):1471. PubMed ID: 32993590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort.
    Bae JH; Moon MK; Oh S; Koo BK; Cho NH; Lee MK
    Diabetes Metab J; 2020 Jun; 44(3):458-469. PubMed ID: 31950769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in cardiovascular risk factors and performance of the Framingham Risk Score and the Pooled Cohort Equations.
    Rospleszcz S; Thorand B; de Las Heras Gala T; Meisinger C; Holle R; Koenig W; Mansmann U; Peters A
    J Epidemiol Community Health; 2019 Jan; 73(1):19-25. PubMed ID: 30262553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing six cardiovascular risk prediction models in Haiti: implications for identifying high-risk individuals for primary prevention.
    Yan LD; Lookens Pierre J; Rouzier V; Théard M; Apollon A; St Preux S; Kingery JR; Jamerson KA; Deschamps M; Pape JW; Safford MM; McNairy ML
    BMC Public Health; 2022 Mar; 22(1):549. PubMed ID: 35305599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and potential years of life lost attributable to non-optimal glycaemic control in men and women with diabetes in the United Arab Emirates: a population-based retrospective cohort study.
    Al-Shamsi S; Govender RD; Soteriades ES
    BMJ Open; 2019 Sep; 9(9):e032654. PubMed ID: 31501134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Cardiovascular Risk Prediction Models Among People Living With HIV: A Systematic Review and Meta-analysis.
    Soares C; Kwok M; Boucher KA; Haji M; Echouffo-Tcheugui JB; Longenecker CT; Bloomfield GS; Ross D; Jutkowtiz E; Sullivan JL; Rudolph JL; Wu WC; Erqou S
    JAMA Cardiol; 2023 Feb; 8(2):139-149. PubMed ID: 36576812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of China-PAR and Framingham risk score in assessment of 10-year cardiovascular disease risk in Chinese hypertensive patients.
    Chen X; Tu Q; Wang D; Liu J; Qin Y; Zhang Y; Xiang Q
    Public Health; 2023 Jul; 220():127-134. PubMed ID: 37315498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for recurrent cardiovascular disease in middle-eastern adults: a retrospective study.
    Govender RD; Al-Shamsi S; Soteriades ES; Regmi D
    BMC Cardiovasc Disord; 2019 Nov; 19(1):253. PubMed ID: 31711429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Disease Risk Prediction in the HIV Outpatient Study.
    Thompson-Paul AM; Lichtenstein KA; Armon C; Palella FJ; Skarbinski J; Chmiel JS; Hart R; Wei SC; Loustalot F; Brooks JT; Buchacz K
    Clin Infect Dis; 2016 Dec; 63(11):1508-1516. PubMed ID: 27613562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Cardiovascular Risk Factors and 10-Years Risk for Coronary Heart Disease in the United Arab Emirates.
    Shehab A; Bakir S; Sabbour H; Elnour AA; Mahmeed WA; Salam AM; Kholy DE
    Curr Diabetes Rev; 2023; 19(3):e210422203892. PubMed ID: 35593359
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.